Enzymatica AB
ENZY | ST
Overview
Corporate Details
- ISIN(s):
- SE0003943620 (+4 more)
- LEI:
- 529900HNJP0335URJQ76
- Country:
- Sweden
- Address:
- Ideon Science Park, 223 70 Lund
- Website:
- https://www.enzymatica.se/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Enzymatica AB is a life science company that develops and sells medical devices for infection-related diseases. The company's core focus is a proprietary barrier technology that utilizes marine enzymes to create a protective layer on mucous membranes, deactivating viruses and preventing illness. Its main product is ColdZyme®, an oral mouth spray clinically documented to protect against the common cold virus and shorten the duration of symptoms. Enzymatica's products are aimed at the self-care market to treat and prevent diseases and symptoms in the upper respiratory tract.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Enzymatica AB.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Enzymatica AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Enzymatica AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-12 | Helene Willberg | Other | Buy | 48,000 | 147,840.00 SEK |
